BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18220763)

  • 21. [Pitfalls in treatment with oral antidiabetic agents].
    Perusicová J
    Vnitr Lek; 1998 Jan; 44(1):30-5. PubMed ID: 9750481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral antidiabetics].
    Bäbler M
    Schweiz Rundsch Med Prax; 1972 Feb; 61(8):242-6. PubMed ID: 4659095
    [No Abstract]   [Full Text] [Related]  

  • 23. [The use of oral antidiabetics].
    Kangas T
    Duodecim; 1974; 90(4):282-94. PubMed ID: 4603906
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacologic treatment of diabetes].
    De Montigny P; Clerc C; Descarpentries C
    Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological treatment of type 2 diabetes.
    Hermans MP; Buysschaert M
    Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
    Fisman EZ; Motro M; Tenenbaum A
    Adv Cardiol; 2008; 45():154-170. PubMed ID: 18230961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
    Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergency management of oral hypoglycemic drug toxicity.
    Rowden AK; Fasano CJ
    Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus.
    Koski RR
    Diabetes Educ; 2006; 32(6):869-76. PubMed ID: 17102154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pioglitazone/glimepiride (Duetact) for diabetes.
    Med Lett Drugs Ther; 2007 Jan; 49(1253):9-11. PubMed ID: 17261966
    [No Abstract]   [Full Text] [Related]  

  • 32. [Measures to meet the side effects of the orally administered antihyperglycemic drugs].
    Ishii J; Inoue I
    Nihon Rinsho; 1997 Nov; 55 Suppl():104-13. PubMed ID: 9434452
    [No Abstract]   [Full Text] [Related]  

  • 33. Drugs for type 2 diabetes.
    Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
    Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
    J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipids behavior and adverse effects for oral antidiabetic agents in patients with Type 2 diabetes treated with sulfonylureas alone based on systematic review.
    Mukai J; Tada H; Watanabe Y; Miura M; Katsuyama S; Shoji T; Mohri K; Eto M; Suzuki T
    Yakugaku Zasshi; 2007 Oct; 127(10):1747-56. PubMed ID: 17917433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 2 diabetes therapy. A pathophysiologically based approach.
    Mayerson AB; Inzucchi SE
    Postgrad Med; 2002 Mar; 111(3):83-4, 87-92, 95. PubMed ID: 11912999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral combination therapy for type 2 diabetes.
    Charpentier G
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S70-6. PubMed ID: 12324989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of type 2 diabetes mellitus.
    Feinglos MN; Bethel MA
    Med Clin North Am; 1998 Jul; 82(4):757-90. PubMed ID: 9706120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract]   [Full Text] [Related]  

  • 40. [Possibilities and limits of oral diabetes therapy].
    Bruneder H
    Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.